Related Experiment Video
Updated: Feb 12, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Published on: September 16, 2022
Echinococcus granulosus: Cure for Cancer Revisited
Shiwanthi L Ranasinghe1, Donald P McManus1
1Molecular Parasitology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Abstract:
Whereas a number of parasites are well recognized risk factors for a number of different cancers in mammalian hosts, there is limited information on the ability of parasitic organisms to induce anticancer effects. There are conflicting reports that echinococcosis, caused by the canine tapeworm Echinococcus granulosus, can decrease or increase cancer risk. This review considers both indirect anticancer effects as the result of adaptive immunity generated against certain echinococcal antigens and the direct effect of molecules released by E. granulosus whose activity directly inhibits cancer cell migration and growth. In conclusion, E. granulosus probably secretes molecules that can be developed as anticancer therapeutics in future.
Insights
The canine tapeworm Echinococcus granulosus may offer anticancer benefits. Molecules secreted by this parasite show potential for developing future cancer therapeutics by inhibiting tumor cell growth and migration.
Area of Science:
- Parasitology and Oncology
- Immunology and Cancer Biology
Background:
- Parasites are known cancer risk factors, but their potential anticancer effects are understudied.
- Echinococcosis, caused by Echinococcus granulosus, has conflicting associations with cancer risk.
- Limited data exists on parasitic organisms inducing anticancer effects in mammalian hosts.
Purpose of the Study:
- To review the indirect and direct anticancer effects of Echinococcus granulosus.
- To explore the potential of E. granulosus-derived molecules as anticancer therapeutics.
Main Methods:
- Literature review of studies on Echinococcus granulosus and cancer.
- Analysis of adaptive immunity generated against echinococcal antigens.
- Investigation of direct effects of E. granulosus molecules on cancer cell behavior.
Main Results:
- Echinococcal antigens may elicit indirect anticancer effects via adaptive immunity.
- Molecules secreted by E. granulosus directly inhibit cancer cell migration and growth.
- Evidence suggests a dual role of echinococcosis in cancer risk modulation.
Conclusions:
- Echinococcus granulosus likely secretes bioactive molecules with anticancer properties.
- These molecules hold promise for the development of novel anticancer therapeutics.
- Further research is warranted to isolate and characterize these therapeutic compounds.
Related Concept Videos
Curing of Concrete
Curing Methods
Accelerated Curing of Concrete
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

